ArticlePharmacoEconomics2017
Evaluation of Healthcare Interventions and Big Data: Review of Associated Data Issues.
Article in PharmacoEconomics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- How to customize common data models for rare diseases: an OMOP-based implementation and lessons learned.Orphanet journal of rare diseases · 2024Article
- Spatio-temporal modelling of referrals to outpatient respiratory clinics in the integrated care system of the Morecambe Bay area, England.BMC health services research · 2024Article
- Methods Used in the Development of Common Data Models for Health Data: Scoping Review.JMIR medical informatics · 2023Article
- Recommendations to overcome barriers to the use of artificial intelligence-driven evidence in health technology assessment.Frontiers in public health · 2023Article
- Demonstrating Benefit-Risk Profiles of Novel Therapeutic Strategies in Kidney Transplantation: Opportunities and Challenges of Real-World Evidence.Transplant international : official journal of the European Society for Organ Transplantation · 2022Article
- Solving the Evidence Interpretability Crisis in Health Technology Assessment: A Role for Mechanistic Models?Frontiers in medical technology · 2022Article
- Common Problems, Common Data Model Solutions: Evidence Generation for Health Technology Assessment.PharmacoEconomics · 2021Article
- The Academic Viewpoint on Patient Data Ownership in the Context of Big Data: Scoping Review.Journal of medical Internet research · 2020Article
- Article
- A Review of the Challenges of Using Biomedical Big Data for Economic Evaluations of Precision Medicine.Applied health economics and health policy · 2019Review
- Patient-Community Perspectives on Real-World Evidence: Enhancing Engagement, Understanding, and Trust.The patient · 2019Article
- Real World Evidence: Can We Really Expect It to Have Much Influence?Drugs - real world outcomes · 2019Article
- Developing a Physical Activity Ontology to Support the Interoperability of Physical Activity Data.Journal of medical Internet research · 2019Article
- Data integration of electronic medical record under administrative decentralization of medical insurance and healthcare in China: a case study.Israel journal of health policy research · 2019Article
- Genetic and Genomic Consultation: Are We Ready for Direct-to-Consumer Telegenetics?Frontiers in genetics · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although the analysis of 'big data' holds tremendous potential to improve patient care, there remain significant challenges before it can be realized. Accuracy and completeness of data, linkage of disparate data sources, and access to data are areas that require particular focus. This article discusses these areas and shares strategies to promote progress. Improvement in clinical coding, innovative matching methodologies, and investment in data standardization are potential solutions to data validation and linkage problems. Challenges to data access still require significant attention with data ownership, security needs, and costs representing significant barriers to access.
Indexed as
Identifiers
28474299What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.